Safety and Efficacy of a Drug Delivery System in Glaucoma

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vistakon Pharmaceuticals
• Treatments: Bimatoprost; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Man or woman 21 years of age or greater

• Open angle glaucoma or ocular hypertension

• Corrected visual acuity in each eye of 20/200 or better

Exclusion Criteria:

• Previous glaucoma intraocular surgery or refractive surgery

• Planned contact lens use during the study

• Clinically significant ocular or systemic disease that might interfere with the study

• Use of chronic corticosteroids by any route